{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:01:04Z","timestamp":1774285264173,"version":"3.50.1"},"reference-count":16,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,2,13]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>A female patient in her 60s with bipolar disorder type 1 underwent robot-assisted radical cystectomy with ileal conduit for muscle-invasive bladder cancer. Postoperatively, she continued her regular lithium dose of 600\u2009mg nightly. By postoperative day 4, her lithium level had risen unexpectedly to 1.38\u2009mmol\/L, necessitating temporary discontinuation. Lithium was restarted on postoperative day 12 at 300\u2009mg nightly (50% dose reduction), achieving therapeutic levels (0.63\u2009mmol\/L) within 3\u2009weeks. She remained psychiatrically and medically stable during 3\u2009months of follow-up. We propose that lithium reabsorption through the absorptive intestinal mucosa of the ileal conduit contributed to the elevated lithium levels and need for dose reduction. Currently, limited guidance exists from urological and psychiatric associations regarding pharmacokinetic interactions in patients with urinary diversion taking lithium. Based on this case, we recommend: increased lithium monitoring in the postoperative period, consideration of prophylactic dose reduction in the acute postoperative period and close psychiatric follow-up for safe re-titration.<\/jats:p>","DOI":"10.1136\/bcr-2025-267862","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:10:15Z","timestamp":1774282215000},"page":"e267862","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Elevations in serum lithium levels postcystectomy and ileal conduit"],"prefix":"10.1136","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1990-1824","authenticated-orcid":false,"suffix":"MD","given":"Mary Elizabeth","family":"Nguyen","sequence":"first","affiliation":[{"name":"Psychiatry, St Joseph\u2019s Healthcare Hamilton, Hamilton, Ontario, Canada"},{"name":"McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"MD, PhD, F","given":"Jeremy","family":"Cepek","sequence":"additional","affiliation":[{"name":"Urology, Grand River Hospital, Kitchener, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"MD FRCPC","given":"Jordon","family":"Charlebois","sequence":"additional","affiliation":[{"name":"Psychiatry, St Joseph\u2019s Healthcare Hamilton, Hamilton, Ontario, Canada"},{"name":"McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"MD, FRCPC","given":"Patricia","family":"Rosebush","sequence":"additional","affiliation":[{"name":"Psychiatry, St Joseph\u2019s Healthcare Hamilton, Hamilton, Ontario, Canada"},{"name":"McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"2026032309100882000_19.3.e267862.1","unstructured":"Gontero P , Birtle A , Comp\u00e9rat E , et al . EAU guidelines office: smith EJ. In: EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS). Arnhem (NL): European Association of Urology Guidelines Office, 2025. Available: https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Non-muscle-Invasive-BC-2025.pdf"},{"key":"2026032309100882000_19.3.e267862.2","unstructured":"van der Heijden AG , Bruins HM , Carrion A , et al . EAU guidelines office: smith EJ. In: EAU guidelines on muscle-invasive and metastatic bladder cancer. Arnhem (NL): European Association of Urology Guidelines Office, 2025. Available: https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-Guidelines-on-Muscle-Invasive-Bladder-Cancer-2025.pdf"},{"key":"2026032309100882000_19.3.e267862.3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1464-410X.1987.tb05050.x","article-title":"Methotrexate toxicity associated with an ileal conduit","volume":"60","author":"Bowyer","year":"1987","journal-title":"Br J Urol"},{"key":"2026032309100882000_19.3.e267862.4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0022-5347(17)62438-8","article-title":"Syncope following ureterosigmoidostomy","volume":"101","author":"Savarirayan","year":"1969","journal-title":"J Urol"},{"key":"2026032309100882000_19.3.e267862.5","unstructured":"National Institute for Health and Care Excellence . Bipolar disorder: assessment and management. clinical guideline [CG185]. London: NICE; 2014. Available: https:\/\/www.nice.org.uk\/guidance\/cg185"},{"key":"2026032309100882000_19.3.e267862.6","doi-asserted-by":"publisher","DOI":"10.2174\/1871527318666191114095249"},{"key":"2026032309100882000_19.3.e267862.7","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/bmj.320.7241.1037\/a","article-title":"Lithium toxicity after urinary diversion with ileal conduit","volume":"320","author":"Alhasso","year":"2000","journal-title":"BMJ"},{"key":"2026032309100882000_19.3.e267862.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00020-X"},{"key":"2026032309100882000_19.3.e267862.9","unstructured":"U.S. Food and Drug Administration . Methotrexate injection [prescribing information]. Silver Spring (MD) U.S. Food and Drug Administration; 2023."},{"key":"2026032309100882000_19.3.e267862.10","unstructured":"Winter ME . Basic Clinical Pharmacokinetics. 6th edn. Philadelphia (PA): Wolters Kluwer, 2017."},{"key":"2026032309100882000_19.3.e267862.11","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V103666"},{"key":"2026032309100882000_19.3.e267862.12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5688\/aj690588","article-title":"Therapeutic Drug Management of Lithium","volume":"69","author":"Cates","year":"2005","journal-title":"Am J Pharm Educ"},{"key":"2026032309100882000_19.3.e267862.13","doi-asserted-by":"publisher","DOI":"10.1007\/BF01870322"},{"key":"2026032309100882000_19.3.e267862.14","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/764325","article-title":"Metabolic changes after urinary diversion","volume":"2011","author":"Van der Aa","year":"2011","journal-title":"Adv Urol"},{"key":"2026032309100882000_19.3.e267862.15","unstructured":"National institute for health and care excellence (NICE) . Depression in adults: treatment and management. NICE guideline [NG222]; 2022. Available: https:\/\/www.nice.org.uk\/guidance\/ng222"},{"key":"2026032309100882000_19.3.e267862.16","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.1999.10106.x"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-267862","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:10:17Z","timestamp":1774282217000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-267862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,23]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bcr-2025-267862"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-267862","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}